140 related articles for article (PubMed ID: 38682445)
1. Optimization of single-needle red cell exchange in patients with sickle cell disease.
Kearney L; Bosnick R; Phillips H; Ghio A; Cullen D; Sweat L; Zheng Y
J Clin Apher; 2024 Jun; 39(3):e22118. PubMed ID: 38682445
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell exchange in children with sickle cell disease.
Elenga N; Vantilcke V; Martin E; Cuadro E; Selles P; Basset T
Int J Hematol; 2022 Jan; 115(1):107-113. PubMed ID: 34550539
[TBL] [Abstract][Full Text] [Related]
3. Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
Ziemba Y; Xu C; Fomani KM; Nandi V; Yuan T; Rehmani S; Sachais BS; Appiah-Kubi AO; Aygun B; Louie JE; Shi PA
Transfusion; 2021 Feb; 61(2):526-536. PubMed ID: 33368343
[TBL] [Abstract][Full Text] [Related]
4. Automated red cell exchange procedures in patients with sickle cell disease.
Kozanoglu I; Boga C; Ozdogu H; Sezgin N; Kizilkilic E; Kural M
Transfus Apher Sci; 2007 Jun; 36(3):305-12. PubMed ID: 17584530
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease.
Sarode R; Ballas SK; Garcia A; Kim HC; King K; Sachais B; Williams LA
J Clin Apher; 2017 Oct; 32(5):342-367. PubMed ID: 27723109
[TBL] [Abstract][Full Text] [Related]
6. Metabolic impact of red blood cell exchange with rejuvenated red blood cells in sickle cell patients.
Gehrke S; Shah N; Gamboni F; Kamyszek R; Srinivasan AJ; Gray A; Landrigan M; Welsby I; D'Alessandro A
Transfusion; 2019 Oct; 59(10):3102-3112. PubMed ID: 31385330
[TBL] [Abstract][Full Text] [Related]
7. Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease.
Shrestha A; Jawa Z; Koch KL; Rankin AB; Xiang Q; Padmanabhan A; Karafin MS; Field JJ
J Clin Apher; 2015 Dec; 30(6):353-8. PubMed ID: 25790325
[TBL] [Abstract][Full Text] [Related]
8. Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.
Lopez Domowicz DA; Welsby I; Esther CR; Zhu H; Marek RD; Lee G; Shah N; Poisson JL; McMahon TJ
Blood Transfus; 2020 May; 18(3):200-207. PubMed ID: 32203007
[TBL] [Abstract][Full Text] [Related]
9. Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange.
Kamyszek RW; Raval JS; Srinivasan AJ; Ansari AK; Evans BA; Rollins-Raval MA; Poisson JL; Shah NR; Welsby IJ
Transfusion; 2019 Aug; 59(8):2622-2628. PubMed ID: 31161685
[TBL] [Abstract][Full Text] [Related]
10. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
11. Red cell exchange: special focus on sickle cell disease.
Kim HC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):450-6. PubMed ID: 25696893
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the depletion-red cell exchange program with the Spectra Optia and the isovolemic hemodilution-red cell exchange method with the COBE Spectra in sickle cell disease patients.
Poullin P; Sanderson F; Bernit E; Brun M; Berdah Y; Badens C
J Clin Apher; 2016 Oct; 31(5):429-33. PubMed ID: 26274351
[TBL] [Abstract][Full Text] [Related]
13. Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease.
Michot JM; Driss F; Guitton C; Moh Klaren J; Lefebvre F; Chamillard X; Gallon P; Fourn E; Pela AM; Tertian G; Le Bras P; Chantalat-Auger C; Delfraissy JF; Goujard C; Lambotte O
Transfusion; 2015 Feb; 55(2):357-63. PubMed ID: 25251746
[TBL] [Abstract][Full Text] [Related]
14. Blood bank issues associated with red cell exchanges in sickle cell disease.
Sarode R; Altuntas F
J Clin Apher; 2006 Dec; 21(4):271-3. PubMed ID: 17177280
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic red blood cell exchange in a child with sickle cell anaemia using the Spectra Optia® apheresis system.
Sipurzynski-Budrass S; Sovinz P; Lanzer G; Schallmoser K
Transfus Med; 2014 Jun; 24(3):184-6. PubMed ID: 24629092
[No Abstract] [Full Text] [Related]
16. Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.
Mercure-Corriveau N; Crowe EP; Vozniak S; Feng X; Rai H; Van Denakker T; Zakieh A; Grabowski MK; Lanzkron S; Tobian AAR; Bloch EM
Transfusion; 2024 Jan; 64(1):124-131. PubMed ID: 38069526
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease.
Quirolo K; Bertolone S; Hassell K; Howard T; King KE; Rhodes DK; Bill J
Transfusion; 2015 Apr; 55(4):775-81. PubMed ID: 25330984
[TBL] [Abstract][Full Text] [Related]
18. Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature.
Kelly S; Quirolo K; Marsh A; Neumayr L; Garcia A; Custer B
Transfusion; 2016 Nov; 56(11):2877-2888. PubMed ID: 27759170
[TBL] [Abstract][Full Text] [Related]
19. Improved method for automated red cell exchange in sickle cell disease.
Castro O; Finke-Castro H; Coats D
J Clin Apher; 1986; 3(2):93-9. PubMed ID: 3516980
[TBL] [Abstract][Full Text] [Related]
20. Use of red blood cell exchange for treating acute complications of sickle cell disease.
Kozanoglu I; Ozdogu H
Transfus Apher Sci; 2018 Feb; 57(1):23-26. PubMed ID: 29525569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
